Marketwire -- London, UK; Brentwood, TN, US: 24 October 2008 - Protherics PLC
("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, confirms, in accordance
with Rule 2.10 of the City Code on Takeovers and Mergers (the"Code"), that
as at the close of business on 23 October 2008, the
Company has 350,427,481 ordinary shares of 2 pence each in issue and
admitted to trading on the London Stock Exchange under the UK ISIN
Code GB0007029209.
